Public Companies
What Is Going on With Silo Pharma (SILO) Stock Today?
Source: Bukhta Yurii / Shutterstock.com
Silo Pharma (NASDAQ:SILO) stock is in the news Wednesday as investors react to the company uplisting shares.
This…
Silo Pharma (NASDAQ:SILO) stock is in the news Wednesday as investors react to the company uplisting shares.
This saw shares of SILO stock switch from the OTC Market to the Nasdaq Exchange yesterday. To go along with that, the company announced a stock offering of 1 million shares priced at $5 each. The offering ends tomorrow.
That offering has the company expecting to raise $5 million before underwriting expenses. It will use these funds for ” product development, marketing, and working capital and general corporate purposes.”
Investors will also note that the offering includes a 45-day option for underwriters to purchase additional shares. This allows them to acquire up to 150,000 more shares of SILO stock at the offering price.
What Does Silo Pharma Do?
Silo Pharma is a development-stage biopharmaceutical company. Its major focus is on the development of treatments for PTSD, Alzheimer’s, and other rare neurological disorders. That includes combining traditional therapeutics with psychedelic research.
Shares of SILO stock are seeing heavy trading on Wednesday after its uplisting. This has some 1.6 million shares of the stock on the move today. To put that in perspective, the company’s daily average trading volume is closer to 7,000 shares.
SILO stock is up 3.7% as of Wednesday afternoon but is down 20.3% year-to-date.
There’s more stock market news traders will want to know about below!
We’ve got all of the latest stock coverage traders need to know about for Wednesday! A few examples include why shares of Taiwan Semiconductor (NYSE:TSM), BTRS (NASDAQ:BTRS), and Casava Sciences (NASDAQ:SAVA) stock on the move. You can learn more on these matters at the following links!
More Wednesday Stock Market News
- Why Is Taiwan Semiconductor (TSM) Stock Down Today?
- BTRS Stock Soars 60% on Acquisition News
- Why Is Cassava Sciences (SAVA) Stock Heating Up Today?
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
More From InvestorPlace
- Buy This $5 Stock BEFORE This Apple Project Goes Live
- The Best $1 Investment You Can Make Today
- Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
The post What Is Going on With Silo Pharma (SILO) Stock Today? appeared first on InvestorPlace.
psychedelic investors shares trading nasdaq otc capital silo pharma silo research-
Psychedelics1 week ago
Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder
-
Law & Regulation1 week ago
Going concern warnings cloud Xtacy Therapeutics’ shrunk losses
-
Psilocybin1 week ago
Are Shrooms Legal in Oregon: Full Guide
-
Law & Regulation1 week ago
Numinus reports declining revenue as the company restructures
-
Psychedelics1 week ago
Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)
-
Psychedelics1 week ago
Psyence Group’s NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
-
Psychedelics1 week ago
Atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
-
Law & Regulation7 days ago
Clearmind signs agreement with Hebrew University for psychedelic compound rights